Galmar Consulting Pty Limited

Status: Registered
Australian Company Number: 157860967
Australian Business Number: 48157860967
Registration date: 18th April 2012
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated

Description

Galmar Consulting Pty Limited is a limited by shares Australian proprietary company. Located at QLD 4216 since 2014-03-25 the company is, as the updated on 2014-03-26 ABN database shows, registered. Known company numbers for Galmar Consulting Pty Limited are as follows: ACN - 157860967, Australian Business Number - 48157860967. Galmar Consulting is one of the trading names this company has used, to be exact, the trading names list includes 1 position that is Galmar Consulting since 2012-04-18. This Australian proprietary company was previously located in QLD 4068 (from 2012-04-18 to 2014-03-25).

Details for ABN 48157860967

Type: Australian Private Company

ABN Status

Status From To
Active 18th April 2012 current

Main Name

Name From To
Galmar Consulting Pty Limited 18th April 2012 current

Trading Names

Name From To
Galmar Consulting 18th April 2012 current

Main Location

Location From To
QLD 4216 25th March 2014 current
QLD 4068 18th April 2012 25th March 2014

Advertisements

Find company

QLD 4216 Location

2024 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.